Um Simplicitybio

Über das Unternehmen

SimplicityBio’s vision is to be one of the world’s leading biomarker discovery companies in the molecular diagnostic market, providing to our clients services and products based on robust signatures using multiple biomarkers. The company's range of services include biomarker discovery and ranking, signature creation, and existent signature improvement. Furthermore, it develops science, IP, and white paper technologies for its clients. SimplicityBio was founded in 2013 by Matthew Hall, Pedro Faustino, and Miguel Barreto and is based in Monthey.